Home » Authors » Kim Coghill

Articles by Kim Coghill

British Government Fostering Development With U.S. Biotechs

Feb. 20, 2003

Dolly, A Symbol Of Biotech, Dies At 6 From Lung Disease

Feb. 18, 2003

GSK's Decision To Limit Sales Rankles Some Representatives

Feb. 18, 2003

GSK's Decision To Limit Sales Rankles Some Representatives

Feb. 18, 2003

Dolly, A Symbol Of Biotech, Dies At 6 From Lung Disease

Feb. 18, 2003

RAC Says Stopping Trials With Retroviral Vectors Not Warranted

Feb. 14, 2003

RAC Says Stopping Trials With Retroviral Vectors Not Warranted

Feb. 14, 2003

HHS Secretary Calls For Funding To Meet Needs Of Terror Threats

Feb. 13, 2003

HHS Secretary Calls For Funding To Meet Needs Of Terror Threats

Feb. 13, 2003

Gilead Reports Positive Results From Viread, FTC HIV Studies

Feb. 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...